0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Research Letter  | 
Low-Dose Decitabine for Patients With Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation:  A Pilot Therapeutic Study
Yue Han, MD, PhD; Yaqiong Tang, MD; Jia Chen, MD; et al.
JAMA Oncology
Original Investigation  | 
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia
Kami J. Maddocks, MD; Amy S. Ruppert, MAS; Gerard Lozanski, MD; et al.
JAMA
JAMA Diagnostic Test Interpretation  | 
Elevated Lactate Levels in a Non–Critically Ill Patient
Meng Chen, MD; Tiffany Y. Kim, MD; Antonio M. Pessegueiro, MD
JAMA
Editorial  | 
Precision Medicine to Improve the Risk and Benefit of Cancer Care:  Genetic Factors in Vincristine-Related Neuropathy
Howard L. McLeod, PharmD